Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Motor Activity 3 Prostatic Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Behavior 2 Uterine Cervical Neoplasms 1 Smoking Cessation 1 Patient Compliance 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Medication Adherence 1 Lymphedema 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Chronic Pain 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Anastrozole 2 beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Surveys and Questionnaires 1 Specimen Handling 1 Nutrition Assessment 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Motivational Interviewing 1 Leuprolide 1 Lapatinib 1 Interviews as Topic 1 Goserelin 1 Exercise 1 Diet Therapy 1 Clodronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Motivational Interviewing × Breast × Clear all

NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡